Clinical Trials Logo

Altitude Sickness clinical trials

View clinical trials related to Altitude Sickness.

Filter by:

NCT ID: NCT04993729 Recruiting - Clinical trials for Acute Mountain Sickness (AMS)

Safety and Efficacy of T89 in the Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)

Start date: July 21, 2021
Phase: Phase 3
Study type: Interventional

The specific aim of this double blind, randomized phase III trial is to evaluate the safety and efficacy of T89 in preventing Acute Mountain Sickness (AMS) and relieving the symptoms of AMS after rapid ascent.

NCT ID: NCT04915365 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders With COPD Traveling to High Altitude

Start date: May 1, 2021
Phase: Phase 3
Study type: Interventional

The purpose of this randomized, placebo-controlled double-blind trial is to evaluate the effect of acetazolamide on right heart function at rest in lowlanders with chronic obstructive pulmonary disease (COPD) traveling to high altitude (HA) and developing early signs of altitude-illness.

NCT ID: NCT04557995 Recruiting - Clinical trials for High Altitude Polycythemia

Clinical Efficacy of Erythropheresis in High Altitude Polycythemia

Start date: September 21, 2020
Phase: N/A
Study type: Interventional

The clinical study is aimed to explore the efficacy and safety of erythropheresis in high altitude polycythemia.

NCT ID: NCT04288219 Recruiting - Hypoxia Clinical Trials

Non-Invasive Positive Pressure Ventilation Management of High Altitude Pulmonary Edema

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

Trial of Non-Invasive Positive Pressure Ventilation Management of High Altitude Pulmonary Edema

NCT ID: NCT04251364 Recruiting - Hypoxia, Altitude Clinical Trials

Treatment of Chronic Mountain Sickness

Exp5300
Start date: February 15, 2020
Phase: N/A
Study type: Interventional

This study aims to assess the effect of two drugs for the treatment of chronic mountain sickness in highlanders.

NCT ID: NCT03621410 Recruiting - Clinical trials for Acute Mountain Sickness

T89 in Prevention and Treatment of Acute Mountain Sickness (AMS) During Rapid Ascent

T89-AMS
Start date: June 1, 2018
Phase: Phase 2
Study type: Interventional

To evaluate the safety and efficacy of T89 in preventing Acute Mountain Sickness (AMS) and relieving the symptoms of AMS during rapid ascent.

NCT ID: NCT03446898 Recruiting - Clinical trials for Residence or Prolonged Visit at High Altitude as the Cause of Mountain Sickness

A Study of the Effect of High Altitudes on Physiological and Metabolic Markers in Adults Living at Qinghai-Tibet Plateau for Work Purpose

Start date: July 22, 2017
Phase: N/A
Study type: Observational

This ambispective cohort study aims to evaluate the effect of high altitudes environment on human's physiological and metabolic markers, specific markers of main human systems, and incidence rate and severity of chronic mountain sickness (CMS).

NCT ID: NCT02972411 Recruiting - Altitude Sickness Clinical Trials

Controlled Hyperventilation as Prophylaxis for Acute Mountain Sickness

Start date: October 2016
Phase: N/A
Study type: Interventional

This study evaluates the safety and efficacy of the voluntary ventilatory response as prophylaxis for acute mountain sickness, measured by the Lake Louise Self-Report Score, comparing to a group using acetazolamide.

NCT ID: NCT02780908 Recruiting - Hypoxia Clinical Trials

Cardio-respiratory Responses During Hypoxic Exercise in Individuals Born Prematurely

PreTerm
Start date: April 2016
Phase: N/A
Study type: Interventional

This project will consist of two studies, each investigating resting and exercise cardio-respiratory responses during exposure to hypoxia in individuals born prematurely and individuals born at full term of two different age groups: Kids (10-14 yrs) and Adults (18-22 yrs).Additional study will be performed on a preterm adult cohort (15 participants) that will investigate potential differences between hypobaric and normobaric hypoxia as outlined in the following section.

NCT ID: NCT02391519 Recruiting - Pregnancy Clinical Trials

Effects of High Altitude on AMPK Activation

Start date: January 2016
Phase:
Study type: Observational

Pregnancy elicits adaptive changes in uteroplacental blood flow, which are altered at high altitude and may contribute to the observed 3-fold increase in intrauterine growth restriction (IUGR) and preeclampsia (PreE). The investigators propose to collect myometrial, cord blood, and placental tissue samples from women at high altitude (Summit County) and low altitude (Denver) in Colorado in order to determine if residence at altitude during pregnancy changes the vasoreactivity of myometrial arteries (MA). If altered MA vasoreactivity is found, further studies may be able to link these changes to the increased rates of PreE and IUGR at altitude and contribute to the understanding of these two disorders.